Could be because of the Yale study published early this year as well as the one on frameshifting (brilliantly done and well written report published in Nature) that Jay Bhattacharya referred to. IMO Jessica Rose (who was introduced to the world by the FDA in one of their blatant ADCOMs) had input into the Nature study because she was writing about the topic two years previously. She was at a conference in Japan last year and CSL was mentioned!
This could potentially be a headwind for CSL's non vaccine business if public opinion changes dramatically.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$238.86 |
Change
-2.190(0.91%) |
Mkt cap ! $115.6B | |||
| Open | High | Low | Value | Volume |
| $242.00 | $242.00 | $237.72 | $176.2M | 723.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1620 | $238.86 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $238.88 | 1181 | 1 |
View Market Depth
| Last trade - 16.10pm 13/06/2025 (20 minute delay) ? |
| CSL (ASX) Chart |